CAR T Cell Therapy And Other Technologies Emerging In Oncology Research

CAR T cell therapy, or adoptive cell therapy, is a type of treatment in which a patient’s own T cells are manipulated in a lab by adding an artificial receptor, or a “CAR.” In conjunction with the patient’s own T cells, the CAR enables the final product to produce chemicals in the hopes that the “enhanced” product or cells will bind to the cancer cells and kill them.

Some of these unique therapies have already been approved by the US Food and Drug Administration (FDA) and are the first steps toward further groundbreaking science.

In this webinar, Emile Youssef, Premier Research’s Executive Medical Director, reviews the operational and clinical pathways that are helping to bring these technologies to patients.